Granulocyte Dysfunction in Hematological Disorders

References

• Matzner Y. Neutrophil function studies in clinical medicine. Trans Med Rev 1987; 1: 171–181
   PubMedGoogle Scholar
• Suda T, Onai T, Maekawa T. Studies on abnormal polymorphonuclear neutrophils in acute myebgenous leukemia: Clinical significance and changes after chemotherapy. Am J Hematol 1983; 15: 45–56
   PubMed Web of Science ®Google Scholar
• Bendix-Hansen K. Myeloperoxidase deficient polymorphonuclear leucocytes in leukaemia and allied disorders. Dan Med Bull 1988; 35: 501–520
   PubMed Web of Science ®Google Scholar
• Mazzone A, Ricevuti G, Rossi M. Prognostic significance of functional defects of granulocytes in myeloproliferative disease. Oncology 1986; 43: 176–182
   PubMed Web of Science ®Google Scholar
• Davey F R, Erber W N, Gatter K C. Abnormal neutrophils in acute myeloid leukemia and myelodysplastic syndrome. Human Pathol 1988; 19: 454–459
   PubMed Web of Science ®Google Scholar
• Matsuo T, Tomonaga M, Kuriyama K. CFU-C abnormalities and cytochemical defects in bone marrow of adult patients during remission of acute leukemia. Leuk Res 1985; 9: 613–616
   PubMed Web of Science ®Google Scholar
• Miyauchi J, Watanabe Y, Enomoto Y. Lactoferrin-deficient neutrophil polymorphonuclear leucocytes in leukaemias a semiquantitative andultrastructural cytochemical study. J Clin Pathol 1983; 36: 1397–1405
   PubMed Web of Science ®Google Scholar
• Mazzone A, Fioravanti A, Pasotti D. Neutrophil defects are a prognostic factor in acute myeloid leukemia. Haematologica 1988; 73: 11–14
   Google Scholar
• Bottari V, Fattorossi A, Nisini R. Motility and oxidative metabolism of normal polymorphonuclear leukocytes in acute non-lymphoid leukemia in complete remission. Ric Clin Lab 1987; 17: 41–46
   PubMedGoogle Scholar
• Powell B L, Olbrantz P, Bichet D. Altered oxidative product formation in neutrophils of patients recovering from therapy for acute leukemia. Blood 1986; 67: 1624–1630
   PubMed Web of Science ®Google Scholar
• Rosner F, Valmont I, Kozinn P J. Leukocyte function in patients with leukemia. Cancer 1970; 25: 835–842
   PubMed Web of Science ®Google Scholar
• Wachstein M. Alkaline phosphatase activity in normal and abnormal human bone marrow cells. J Lab Clin Med 1946; 31: 1–17
   PubMed Web of Science ®Google Scholar
• Bendix-Hansen K, Helleberg-Rasmussen I. Evaluation of neutrophil alkaline phosphatase (NAP) activity: Untreated myeloid leukaemia, lymphoid leukaemia and normal humans. Scand J Haematol 1985; 34: 264–269
   PubMedGoogle Scholar
• Athens J W, Raab S O, Haab O P. Leukokinetic studies. X. Blood granulocyte kinetics in chronic myelocytic leukemia. J Clin Invest 1965; 44: 765–777
   PubMed Web of Science ®Google Scholar
• Taub R N, Baker M A, Madyastha K R. Masking of neutrophil surface lectin-binding sites in chronic myelogenous leukemia (CML). Blood 1980; 55: 294–298
   PubMed Web of Science ®Google Scholar
• Wysocki H, Wierusz-Wysocka B, Sierkeirka H. Polymorphonuclear neutrophils function in untreated patients with chronic myeloid leukemia. Oncology 1988; 45: 79–83
   PubMed Web of Science ®Google Scholar
• Whittaker J A, Khurshid M, Hughes H R. Neutrophil function in chronic granulocytic leukaemia before and after busulphan treatment. Br J Haematol 1974; 28: 541–549
   PubMed Web of Science ®Google Scholar
• Banerjee T K, Senn H, Holland J F. Comparative studies on localized leukocyte mobilization in patients with chronic myelocytic leukemia. Cancer 1972; 29: 637–644
   PubMed Web of Science ®Google Scholar
• Perillie P E, Finch S. The local exudative cellular response in leukemia. J CHn Invest 1960; 39: 1353–1357
   PubMed Web of Science ®Google Scholar
• Olofsson T, Odeberg H, Olsson I. Granulocyte function in chronic granulocytic leukemia. II. Bactericidal capacity, phagocytic rate, oxygen consumption, and granule protein composition in isolated granulocytes. Hood 1976; 48: 581–593
   Google Scholar
• Anklesaria P N, Advani S H, Bhisey AN. Studies on granulocyte function in patients with chronic myeloid leukemia. Tumori 1985; 71: 317–324
   PubMed Web of Science ®Google Scholar
• Odeberg H, Olofsson T, Olsson I. Granulocyte function in chronic granulocytic leukaemia. I. Bactericidal and metabolic capabilities during phagocytosis in isolated granulocytes. Br J Haematol 1975; 29: 427–441
   PubMed Web of Science ®Google Scholar
• Broxmeyer H E, Mendelsohn N, Moore M AS. Abnormal granulocyte feedback regulation of colony forming and colony stimulating activity-producing cells from patients with chronic myelogenous leukemia. Leukemia Res 1977; 1: 3–12
   Web of Science ®Google Scholar
• Schofield K P, Stone P C, Kelsey P. Quantitative cytochemistry of blood neutrophils in myelodysplastic syndromes and chronic granulocytic leukaemia. Cell Biochem Funct 1983; 1: 92–96
   PubMed Web of Science ®Google Scholar
• Gahrton G, Yataganas X. Quantitative cytochemistry of glycogen in blood cells. Methods and clinical application. Prog Histochem Cytochem 1976; 9: 1–30
   PubMedGoogle Scholar
• Sbarra A J, Shirley W, Selvaraj R J. The role of the phagocyte in host-parasite interactions in. The phagocytic capabilities of leukocytes from myeloproliferative and other neoplastic disorders. Cancer Res 1965; 25: 1199–1206
   PubMed Web of Science ®Google Scholar
• Ackerman G A. Ultrastructural histochemical alteration of the plasma membrane in chronic myelocytic leukemia. Blood 1975; 46: 869–881
   PubMed Web of Science ®Google Scholar
• Baker M A, Taub R N, Whelton C H. Aberrant sialylation of granulocyte membranes in chronic myelogenous leukemia. Blood 1984; 63: 1194–1197
   PubMed Web of Science ®Google Scholar
• Penny R, Galton D AG. Studies on neutrophil function, n. Pathological aspects. Br J Haematol 1966; 12: 633–645
   PubMed Web of Science ®Google Scholar
• Brandt L. Adhesiveness to glass and phagocytic activity of neutrophilic leukocytes in myeloproliferative diseases. Scand J Haematol 1965; 2: 126–136
   PubMedGoogle Scholar
• Rustin G JS, Goldman J M, McCarthy D. An extrinsic factor controls neutrophils alkaline phosphatase in chronic granulocytic leukaemia. Br J Haematol 1980; 45: 381–387
   PubMed Web of Science ®Google Scholar
• Grange M J, Eche F, Bussel A. Granulocytes de leucemie myeloide chronique. Etude fonctionell. Nouv Rev Francaise d'Hematologie 1976; 16: 116–121
   PubMedGoogle Scholar
• Cooper M R, DeChatelet L R, McCall C E. The activated phagocyte of polycythemia vera. Blood 1972; 40: 366–374
   PubMed Web of Science ®Google Scholar
• Samuelsson J, Lindstrom P, Palmblad J. Stimulus-specific defect in oxidative metabolism of polymorphonuclear granulocytes in polycythemia vera. Eur J Haematol 1988; 41: 454–458
   PubMed Web of Science ®Google Scholar
• Corberand J, Laharrague P, DeLarrad B. Phagocytosis in myeloproliferative disorders. Am J Clin Pathol 1980; 74: 301–305
   PubMed Web of Science ®Google Scholar
• Bendix-Hansen K. Myeloperoxidase-deficient polymorphonuclear leucocytes (VII): Incidence in untreated myeloproliferative disorders. Scand J Haematol 1986; 36: 8–10
   PubMedGoogle Scholar
• Perianin A, Labro-Bryskier M T, Marquetry C. Glutathione reductase and nitroblue tetrazolium reduction deficiencies in neutrophils of patients with primary idiopathic myelofibrosis. Clin Exp Immunol 1984; 57: 244–248
   PubMed Web of Science ®Google Scholar
• Hotta T, Utsumi M, Katoh T. Granulocytic and stromal progenitors in the bone marrow of patients with primary myelofibrosis. Scand J Haematol 1985; 34: 251–255
   PubMedGoogle Scholar
• Boogaerts M A, Nelissen V, Roelant C. Blood neutrophil function in primary myelodysplastic syndromes. Br J Haematol 1983; 55: 217–227
   PubMed Web of Science ®Google Scholar
• Martin S, Baldock S C, Ghoneim A TM. Defective neutrophil function and microbicidal mechanisms in the myelodysplastic disorders. J Clin Pathol 1983; 36: 1120–1128
   PubMed Web of Science ®Google Scholar
• Yuo A, Kitagawa S, Okabe T. Recombinant human granulocyte colony-stimulating factor repairs the abnormalities of neutrophils in patients with myelodysplastic syndromes and chronic myelogenous leukemia. Blood 1987; 70: 404–411
   PubMed Web of Science ®Google Scholar
• Uike N, Hashimoto M, Takeichi N. Impaired superoxide production by neutrophils in myelodysplastic syndrome: correlation with bone marrow karyotype. Rinsho Ketsueki 1989; 30: 830–834
   PubMedGoogle Scholar
• Peller S, Kaufman S, Yona R. Functions of polymorphonuclear (PMN) leukocytes of patients with lymphoproliferative diseases. Immunol Letters 1985; 10: 53–56
   PubMed Web of Science ®Google Scholar
• Boggs D R, Fahey J L. Serum protein changes in malignant disease II. Chronic leukaemias, Hodgkin's disease and malignant melanomas. J Natl Cancer Inst 1960; 25: 1381–1390
   Google Scholar
• Jayaswal U, Roath S, Hyde R D. Blood lymphocyte surface markers and clinical findings in chronic lymphoproliferative disorders. Br J Haematol 1977; 37: 207–215
   PubMed Web of Science ®Google Scholar
• Sbarra A J, Shriley W, Selvaraj R J. The role of the phagocyte in host parasite interactions I. The phagocytic capabilities of leukocytes form lymphoproliferative disorders. Cancer Res 1964; 24: 1958–1968
   PubMed Web of Science ®Google Scholar
• Nagler A, Obedeanu N, Tatarsky I. Chemiluminescence response of polymorphonuclear leucocytes to serum-opsonized zymosan–a predictive parameter for infections and prognosis in multiple myeloma patients. Clin Lab Haematol 1988; 10: 365–375
   PubMedGoogle Scholar
• Jayaswal U, Roper S, Roath S. Impairment of neutrophil chemotaxis by serum from patients with chronic lymphoproliferative disease. J Clin Pathol 1983; 36: 449–453
   PubMed Web of Science ®Google Scholar
• Siegbahn A, Rosen A, Venge P. Production of chemokinetic inhibitory factor (CIF) by normal blood and spleen B lymphocytes. Leukemia Res 1986; 10: 179–186
   PubMed Web of Science ®Google Scholar
• Ehrlich A, Mattison T D. A serum inhibitor of neutrophil chemotaxis associated with hyperglobulinaemia E in a patient with lymphoma, and recurrent skin infection. Br J Dermatol 1984; 110: 709–715
   PubMed Web of Science ®Google Scholar
• Petrini M, Azzara A, Polidori R. Serum factors inhibiting some leukocytic functions in Hodgkin's disease. Clin Immunol Immunopathol 1982; 23: 124–132
   PubMedGoogle Scholar
• Ward P A, Berenberg J L. Defective regulation of inflammatory mediators in Hodgkin's disease: super normal levels of chemotactic factor inactivator. N Engl J Med 1974; 290: 76–80
   PubMed Web of Science ®Google Scholar
• Cheson B D, Plass R R, Rothstein G. Defective opsonization in multiple myeloma. Blood 1980; 55: 602–606
   PubMed Web of Science ®Google Scholar
• Van Epps D E, Williams R C. Suppression of leukocyte chemotaxis by human IgA myeloma components. J Exp Med 1976; 144: 1227–1242
   PubMed Web of Science ®Google Scholar
• Hopen G, Glette J, Matte R. Mechanisms of decreased leucocyte adhesiveness and migration in plasma from patients with IgG myelomatosis. Scand J Haematol 1984; 32: 88–94
   PubMedGoogle Scholar
• MacGregor R R, Negendank W G, Schreiber A D. Impaired granulocyte adherence in multiple myeloma: Relationship to complement system, granulocyte delivery and infection. Blood 1978; 51: 591–599
   PubMed Web of Science ®Google Scholar
• Dammacco F, Miglietta A, Perfetto S C. Impaired chemiluminescence response by neutrophils in patients with multiple myeloma. Scand J Haematol 1986; 37: 289–295
   PubMedGoogle Scholar
• Rustagi P K, Han T, Ziolkowski L. Granulocyte antibodies in leukaemic chronic lymphoproliferative disorders. Br J Haematol 1987; 66: 461–465
   PubMed Web of Science ®Google Scholar
• Falcao R P. Qualitative and functional studies of neutrophils in aplastic anaemia. J Clin Lab Immunol 1985; 18: 27–29
   Google Scholar
• Fassas A, Bruley-Rosset M. Leukocyte migration-inhibitory activity in serum from patients with aplastic anemia. N Engl J Med 1979; 300: 91–92
   PubMed Web of Science ®Google Scholar
• Brubaker L H, Essig L RJ, Mengel C E. Neutrophil life span in paroxysmal nocturnal hemoglobinuria. Blood 1977; 50: 657–662
   PubMed Web of Science ®Google Scholar
• Ebell W, Wahn V, Gebauer H J. Granulozytenfunktionsdefekt, chromosomenanomalien und blutgruppenchimarsimus bei zwei schwestern mit familiarer aplastischer anamia (type Estren-Dameshek). Klin Padiatr 1983; 195: 283–286
   PubMedGoogle Scholar
• Abkowitz J L, Fialkow P J, Niebrugge D J. Pancytopenia as a clonal disorder of a multipotent hematopoietic stem cell. J Clin Invest 1984; 73: 258–261
   PubMed Web of Science ®Google Scholar
• Clark R A, Johnson F L, Klebanoff S J. Defective neutrophil chemotaxis in bone marrow transplant patients. J Clin Invest 1976; 58: 22–31
   PubMed Web of Science ®Google Scholar
• Solomkin J S, Cotta L A, Brodt J K. Neutrophil dysfunction in sepsis. J Surg Res 1984; 36: 407–412
   PubMed Web of Science ®Google Scholar
• Dahl M, Hakansson L, Kreuger A. Polymorphonuclear neutrophil function and infections following splenectomy in childhood. Scand J Haematol 1986; 37: 137–143
   PubMedGoogle Scholar
• Suarez C R, Pickett W C, Bell D H. Effect of low dose methotrexate on neutrophil chemotaxis induced by Ieukotriene B4 and complement CSa. J Rheumatol 1987; 14: 9–11
   PubMed Web of Science ®Google Scholar
• Johnson J D, Summersgill J T, Raff M J. The in vitro effects of methotrexate on the phagocytosis and intracellular killing of Staphylococcus aureus by human neutrophils. Cancer 1986; 57: 2343–2345
   PubMed Web of Science ®Google Scholar
• Pnizanski W, Saito S, DeBoer G. Modulatory activity of chemotherapeutic agents on phagocytosis and intracellular bactericidal activity of human polymorphonuclear and mononuclear phagocytes. Cancer Res 1983; 43: 1420–1425
   PubMed Web of Science ®Google Scholar
• Vaudaux P, Kiefer B, Fomi M. Adriamycin impairs phagocytic function and induces morphologic alterations in human neutrophils. Cancer 1984; 54: 400–410
   PubMed Web of Science ®Google Scholar
• Schleimer R P, Freeland H S, Peters S P. An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of Ieukotriene B4 by purified human neutrophils. J Pharmacol Exp Ther [JP3] 1989; 250: 598–605
   PubMed Web of Science ®Google Scholar